Turk Ilac ve Serumnayi (IST:TRILC) Enterprise Value: ₺3,958 Mil (As of Jul. 03, 2026) ***


IST:TRILC Turk Ilac ve Serum Sanayi IST:TRILC
61 GF Score
Price ₺1.18
GF Value ₺3.60
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is Turk Ilac ve Serumnayi Enterprise Value?

Turk Ilac ve Serumnayi IST:TRILC -2.48% 61 Enterprise Value is ₺3,958 Mil as of Jul. 03, 2026. GuruFocus rates IST:TRILC with a GF Score™ of 61/100 and a GF Value™ of ₺3.60 (Possible Value Trap). The stock has 11 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Turk Ilac ve Serumnayi's Enterprise Value is ₺3,958 Mil. Turk Ilac ve Serumnayi's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 was ₺910 Mil. Therefore, Turk Ilac ve Serumnayi's EV-to-EBIT ratio for today is 4.35.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Turk Ilac ve Serumnayi's Enterprise Value is ₺3,958 Mil. Turk Ilac ve Serumnayi's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was ₺958 Mil. Therefore, Turk Ilac ve Serumnayi's EV-to-EBITDA ratio for today is 4.13.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Turk Ilac ve Serumnayi's Enterprise Value is ₺3,958 Mil. Turk Ilac ve Serumnayi's Revenue for the trailing twelve months (TTM) ended in Sep. 2025 was ₺2,855 Mil. Therefore, Turk Ilac ve Serumnayi's EV-to-Revenue ratio for today is 1.39.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Turk Ilac ve Serumnayi's Enterprise Value is ₺3,958 Mil. Turk Ilac ve Serumnayi's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2025 was ₺777 Mil. Therefore, Turk Ilac ve Serumnayi's EV-to-OCF ratio for today is 5.09.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Turk Ilac ve Serumnayi's Enterprise Value is ₺3,958 Mil. Turk Ilac ve Serumnayi's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was ₺497 Mil. Therefore, Turk Ilac ve Serumnayi's EV-to-FCF ratio for today is 7.97.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Turk Ilac ve Serumnayi  (IST:TRILC) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Turk Ilac ve Serumnayi's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3957.719/910.438
=4.35

Turk Ilac ve Serumnayi's current Enterprise Value is ₺3,958 Mil.
Turk Ilac ve Serumnayi's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺910 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Turk Ilac ve Serumnayi's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=3957.719/957.723
=4.13

Turk Ilac ve Serumnayi's current Enterprise Value is ₺3,958 Mil.
Turk Ilac ve Serumnayi's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺958 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Turk Ilac ve Serumnayi's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3957.719/2854.83
=1.39

Turk Ilac ve Serumnayi's current Enterprise Value is ₺3,958 Mil.
Turk Ilac ve Serumnayi's Revenue for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺2,855 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Turk Ilac ve Serumnayi's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=3957.719/777.355
=5.09

Turk Ilac ve Serumnayi's current Enterprise Value is ₺3,958 Mil.
Turk Ilac ve Serumnayi's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺777 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Turk Ilac ve Serumnayi's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3957.719/496.799
=7.97

Turk Ilac ve Serumnayi's current Enterprise Value is ₺3,958 Mil.
Turk Ilac ve Serumnayi's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺497 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turk Ilac ve Serumnayi Enterprise Value Related Terms


Turk Ilac ve Serumnayi Enterprise Value Historical Data

* Premium members only.

The historical data trend for Turk Ilac ve Serumnayi's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Turk Ilac ve Serumnayi Enterprise Value Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
0.00 2,045.54 2,682.74 2,461.15 4,352.80

Turk Ilac ve Serumnayi Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,937.52 4,352.80 5,512.56 5,381.57 6,403.80

IST:TRILC vs ZTS, UTHR, VTRS: Enterprise Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Turk Ilac ve Serumnayi Enterprise Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's Enterprise Value falls into.


IST:TRILC
61GF Score
Turk Ilac ve Serum Sanayi IST:TRILC
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Turk Ilac ve Serumnayi Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Turk Ilac ve Serumnayi's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

Turk Ilac ve Serumnayi's Enterprise Value for the quarter that ended in Sep. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of ₺3,958 Mil mean?
Turk Ilac ve Serumnayi (IST:TRILC) has a Enterprise Value of ₺3,958 Mil as of Jul. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Turk Ilac ve Serumnayi and its competitors.
Is Turk Ilac ve Serumnayi's Enterprise Value too high?
Turk Ilac ve Serumnayi's current Enterprise Value is ₺3,958 Mil. Overall, Turk Ilac ve Serumnayi has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Turk Ilac ve Serumnayi's Enterprise Value compare to ZTS and UTHR?
Turk Ilac ve Serumnayi's Enterprise Value of ₺3,958 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Turk Ilac ve Serumnayi and its competitors. Turk Ilac ve Serumnayi's current Enterprise Value is ₺3,958 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Turk Ilac ve Serumnayi stock overvalued right now?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi (IST:TRILC) is currently considered Possible Value Trap. The stock's GF Value™ is ₺3.60, compared to a current price of ₺1.18 — trading 67.2% below its estimated fair value. The current Enterprise Value is ₺3,958 Mil. Turk Ilac ve Serumnayi's overall GF Score™ is 61/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Turk Ilac ve Serumnayi (IST:TRILC), the current Enterprise Value is ₺3,958 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Turk Ilac ve Serumnayi (IST:TRILC) Overvalued in 2026?

Based on GuruFocus' analysis, Turk Ilac ve Serumnayi stock appears to be undervalued. The current stock price of ₺1.18 is trading 67.2% below its estimated GF Value™ of ₺3.60. GuruFocus considers Turk Ilac ve Serumnayi to be Possible Value Trap.

Key valuation signals for IST:TRILC:

  • Enterprise Value: ₺3,958 Mil
  • GF Value™: ₺3.60 vs. price of ₺1.18 (67.2% below fair value)
  • GF Score™: 61/100 with 11 warning signs

No single metric tells the full story. See the IST:TRILC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Turk Ilac ve Serumnayi Business Description

Address Bugduz Mahalle Enver Pasa Cadde, No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.
61GF Score

Get the complete analysis for IST:TRILC

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺1.18
Price
₺3.60
GF Value